Drug Screening and Validation Targeting TDP-43 Proteinopathy for Amyotrophic Lateral Sclerosis.

Xin J, Huang S, Wen J, Li Y, Li A, Satyanarayanan SK, Yao X, Su H

Open source

DOI
10.14336/ad.2024.0440
Published
2024 Feb 1
Container
Aging and disease
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.14336/ad.2024.0440,
  title = {Drug Screening and Validation Targeting TDP-43 Proteinopathy for Amyotrophic Lateral Sclerosis.},
  author = {Xin J and Huang S and Wen J and Li Y and Li A and Satyanarayanan SK and Yao X and Su H},
  year = {2024},
  journal = {Aging and disease},
  doi = {10.14336/ad.2024.0440},
  url = {https://doi.org/10.14336/ad.2024.0440}
}

RIS

TY  - JOUR
TI  - Drug Screening and Validation Targeting TDP-43 Proteinopathy for Amyotrophic Lateral Sclerosis.
AU  - Xin J
AU  - Huang S
AU  - Wen J
AU  - Li Y
AU  - Li A
AU  - Satyanarayanan SK
AU  - Yao X
AU  - Su H
PY  - 2024
JO  - Aging and disease
DO  - 10.14336/ad.2024.0440
UR  - https://doi.org/10.14336/ad.2024.0440
ER  - 

APA

J, X., S, H., J, W., Y, L., A, L., SK, S., X, Y., & H, S. (2024). Drug Screening and Validation Targeting TDP-43 Proteinopathy for Amyotrophic Lateral Sclerosis.. Aging and disease. https://doi.org/10.14336/ad.2024.0440

Source records